Community-acquired Infections
📧 Sign up to get email alerts when something new happens for Community-acquired Infections.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-03-05EMA Authorised: Quofenix (delafloxacin meglumine) — A. Menarini Industrie Farmaceutiche Riunite s.r.l.
EMA has authorised Quofenix, a delafloxacin meglumine antibacterial product, for the treatment of community-acquired infections. Decision da…